Skip to content
OpenCapital
Get started

Alto Neuroscience ANRO Q2 2025 earnings

Reported August 13, 2025 · Before market open

EPS-$0.65Miss by $0.08
EPS estimate-$0.57

Next report

Aug 12, 2026 (In 2 weeks)
EPS estimate-$0.71

Financials

Q2 2025

Income statement

See full
Operating income-$18.7M-1.9%
Net income-$17.7M-10.5%
EPS (diluted)-$0.65-8.3%

Balance sheet

See full
Cash & equivalents$148.1M-23.5%
Total debt$25.3M+152%
Total equity$123.4M-31.4%
Total assets$157.9M-20.0%

Cash flow

See full
Operating cash flow-$13.8M-17.8%
Free cash flow-$13.8M-14.5%

Valuation & ratios

Valuation

as of 06/30/25
See full
Market cap$67.68M-76.4%
Enterprise value-$55.1M-153%

Returns & leverage

See full
Return on equity-42.8%—
Debt / equity0.2×+0.1×
Current ratio18.4×-1.4×

Versus estimates

Diluted EPS

Q1 2026-$0.80Miss by $0.24Q4 2025-$0.45Beat by $0.11Q3 2025-$0.52Beat by $0.14
Q2 2025-$0.65Miss by $0.08
Q1 2025-$0.53Beat by $0.06Q4 2024-$0.56Beat by $0.09

Ask the moment Alto Neuroscience reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Alto Neuroscience report Q2 2025 earnings?
Alto Neuroscience (ANRO) reported Q2 2025 earnings on August 13, 2025 before market open.
What were Alto Neuroscience's Q2 2025 revenue and EPS?
Alto Neuroscience reported eps of $-0.65 for Q2 2025.
Did Alto Neuroscience beat estimates in Q2 2025?
EPS missed the consensus estimate of $-0.57 by $0.08.
How did Alto Neuroscience's Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 8.3% from $-0.60.
Where can I find Alto Neuroscience's Q2 2025 SEC filings?
You can read the 10-Q periodic report (0001999480-25-000076) directly on SEC EDGAR. The filing index links above go to sec.gov.